Zobrazeno 1 - 10
of 50
pro vyhledávání: '"John F. Patzer"'
Autor:
II John F. Patzer
Publikováno v:
Artificial Organs. 32:499-508
New detoxification modes of treatment for liver failure that use solid adsorbents to remove toxins bound to albumin in the patient bloodstream are entering clinical evaluations, frequently in head-to-head competition. While generally effective in red
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee0bb807fcf43fca8ff9d081ed4fce00
https://doi.org/10.1111/j.1525-1594.2008.00581.x
https://doi.org/10.1111/j.1525-1594.2008.00581.x
Publikováno v:
Liver Transplantation. 14:1048-1057
Elevated intracranial pressure (ICP) leads to loss of cerebral perfusion, cerebral herniation, and irreversible brain damage in patients with acute liver failure (ALF). Conventional techniques for monitoring ICP can be complicated by hemorrhage and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0022b1e87b86a43e1c2344a24f4412f
https://doi.org/10.1002/lt.21499
https://doi.org/10.1002/lt.21499
Publikováno v:
Regenerative Medicine. 3:575-595
Acute liver disease is a life-threatening condition for which liver transplantation is the only recognized effective therapy. While etiology varies considerably, the clinical course of acute liver failure is common among the etiologies: encephalopath
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4692e7007671f01598e13b6a66de7f9
https://doi.org/10.2217/17460751.3.4.575
https://doi.org/10.2217/17460751.3.4.575
Publikováno v:
Artificial Organs. 31:834-839
Life-threatening, severely elevated intracranial pressure (ICP) is a common feature of acute liver failure (ALF). Perfusion with a bioartificial liver may serve to mitigate rising ICP. A retrospective analysis of ICP measurements in a canine ALF mode
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dba378308a9f9581f0e1d385c06607d2
https://doi.org/10.1111/j.1525-1594.2007.00476.x
https://doi.org/10.1111/j.1525-1594.2007.00476.x
Autor:
John F. Patzer
Publikováno v:
Therapeutic Apheresis and Dialysis. 10:118-124
Toxins that bind to albumin in the bloodstream and are associated with progressing liver failure have proven refractory to removal by conventional hemodialysis. Such toxins can, however, be removed by adding a binder to the dialysate that serves to c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13005be1e09eb382c994cee1d449f535
https://doi.org/10.1111/j.1744-9987.2006.00352.x
https://doi.org/10.1111/j.1744-9987.2006.00352.x
Autor:
John F. Patzer
Publikováno v:
Annals of the New York Academy of Sciences. 944:320-333
Rapid advances in development of bioartificial liver assist devices (BLADs) are exciting clinical interest in the application of BLAD technology for support of patients with acute liver failure. Four devices (Circe Biomedical HepatAssist, Vitagen ELA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::496042c2e84e23da54f9c43bd4d881ca
https://doi.org/10.1111/j.1749-6632.2001.tb03844.x
https://doi.org/10.1111/j.1749-6632.2001.tb03844.x
Publikováno v:
ASAIO Journal. 52:47-58
Bound solute dialysis (BSD), often referred to as "albumin dialysis" (practiced clinically as the molecular adsorbents recirculating system, MARS, or single-pass albumin dialysis, SPAD) or "sorbent dialysis" (practiced clinically as the charcoal-base
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbfddc50bad563f875bcd0b8170bb650
https://doi.org/10.1097/01.mat.0000196524.36394.0d
https://doi.org/10.1097/01.mat.0000196524.36394.0d
Autor:
T A Grogan, M L Fulmer, George V. Mazariegos, Michael E. DeVera, John F. Patzer, Mauricio Giraldo, B P Amiot, David J. Kramer, Roberto Lopez, Yue Zhu
Publikováno v:
American Journal of Transplantation. 2:260-266
The first clinical use of the Excorp Medical Bioartificial Liver Support System (BLSS) in support of a 41-year-old African-American female with fulminant hepatic failure is described. The BLSS is currently in a Phase I/II safety evaluation at the Uni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e20ba9cce2c4c0b791118fa34e5986cb
https://doi.org/10.1034/j.1600-6143.2002.20311.x
https://doi.org/10.1034/j.1600-6143.2002.20311.x
Autor:
Abdul S. Rao, David J. Kramer, Roberto Lopez, George V. Mazariegos, R Kuddus, John F. Patzer, B. Meighen
Publikováno v:
Transplantation. 73:420-429
Background. The potential risk of transmission of porcine endogenous retroviruses (PERV) from xenogeneic donors into humans has been widely debated. Because we were involved in a phase I/II clinical trial using a bioartificial liver support system (B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4736c38a3af5bd7816c62e7e3659f532
https://doi.org/10.1097/00007890-200202150-00017
https://doi.org/10.1097/00007890-200202150-00017
Autor:
A J Rosenbloom, George V. Mazariegos, Y Zhu, M L Fulmer, John F. Patzer, Michael E. DeVera, B P Amiot, M Giraldo, A O Shakil, David J. Kramer, Roberto Lopez, T A Grogan
Publikováno v:
ASAIO Journal. 47:471-475
A Phase I clinical safety evaluation of the Excorp Medical, Inc, Bioartificial Liver Support System (BLSS) is in progress. Inclusion criteria are patients with acute liver failure of any etiology, presenting with encephalopathy deteriorating beyond P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::929af79f395d5b1f4bf1ec8329e304f3
https://doi.org/10.1097/00002480-200109000-00015
https://doi.org/10.1097/00002480-200109000-00015